Teva Sues US FDA To Obtain 180-Day Exclusivity For Its Generic Restasis

 
• By Brenda Sandburg
  
Courthouse Inscription
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products